Locoregional Blocks for Breast Cancer Surgeries

February 18, 2024 updated by: Walaa Youssef Elsabeeny, National Cancer Institute, Egypt
Breast surgeries are common operative procedures that require appropriate postoperative analgesia.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Numerous pain relief techniques, including several new regional anesthesia techniques, are available for control of acute pain after breast surgery.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • female cancer breast patient
  • age from 18- 65

Exclusion Criteria:

  • coagulation defect
  • Patient refusal
  • abnormal kidney and or liver function tests

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: erector spinae block
Procedure: erector spinae block
Erector spinae plane block
Experimental: retrolaminar block
Procedure: retrolaminar block
Retrolaminar block
Experimental: serratus anterior block
Procedure: serratus anterior block
Serratus anterior plane block
Experimental: pectoral nerve block
Procedure: pectoral nerve block
Pectoral nerve block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
time to receive first postoperative analgesic
Time Frame: First 24 hours postoperatively
time to first dose of rescue opioid analgesic
First 24 hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Cancer Institute, Egypt

Investigators

  • Principal Investigator: Walaa Y Elsabeeny, MD, Assistant professor of Anesthesia, Surgical critical care and Pain Management, National Cancer Institute, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2024

Primary Completion (Estimated)

June 15, 2025

Study Completion (Estimated)

July 25, 2025

Study Registration Dates

First Submitted

January 21, 2024

First Submitted That Met QC Criteria

January 21, 2024

First Posted (Actual)

January 30, 2024

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 18, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • AP2312-301-072

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analgesia

Clinical Trials on erector spinae block

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe